STAGE I LUNG CANCER AJCC V8
Clinical trials for STAGE I LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug stop lung cancer before it starts?
Prevention CompletedThis phase II trial tested whether the immunotherapy drug pembrolizumab (Keytruda) can prevent lung cancer in 45 people with high-risk lung nodules or early-stage non-small cell lung cancer. Participants received pembrolizumab intravenously, and researchers tracked tumor response…
Matched conditions: STAGE I LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Heart monitor reveals hidden damage from cancer radiation
Knowledge-focused CompletedThis study looked at 24 people with lung or esophageal cancer who received radiation or chemo-radiation near the heart. Participants wore a small heart monitor to catch any heart changes that might otherwise go unnoticed. The goal was to see how often heart problems occur after s…
Matched conditions: STAGE I LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC